Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lofexidine Combined With Buprenorphine for Reducing Symptoms of Post-Traumatic Stress Disorder (PTSD) and Opioid Use Relapse in Veterans

NCT04360681 is registered in ClinicalTrials.gov with Pharmacotherapies for Alcohol and Substance Use Disorders Alliance as lead sponsor.

NCT NCT04360681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04360681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lofexidine Combined With Buprenorphine for Reducing Symptoms of Post-Traumatic Stress Disorder (PTSD) and Opioid Use Relapse in Veterans
Lead sponsor
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Phase
Phase 2
Overall status
Completed
Start date
March 9, 2021
Completion date
January 29, 2026
Enrollment
84 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-use disorder, post traumatic stress disorder